醫脈通(02192.HK)年度純利跌52.3%至4061.6萬元 末期息0.017元
格隆匯3月24日丨醫脈通(02192.HK)公佈,截至2021年12月31日止12個月,公司收益為2.84億元(人民幣,下同),同比增長33.2%;母公司擁有人應占溢利為4061.6萬元,同比下降52.3%;每股基本盈利6.59分。董事會決議建議末期股息每股股份人民幣0.0170元。
報吿期內,精準營銷及企業解決方案的收益為2.59億元,同比增長34.9%;醫學知識解決方案 的收益為1225.8萬元,同比增長34.5%;智能患者管理解決方案的收益為1338.8萬港元,同比增長6.3%。
儘管新冠疫情導致的出行限制給公司銷售及營銷團隊在安排與主要客户的實體會議方面帶來不便,但疫情為線上醫療會議及教育提供更多機會。因此,疫情並未對集團2021年財務表現造成重大不利影響。於2021年,集團通過營運專業醫師平台繼續錄得強勁增長。
截至2021年12月31日,經計,透過公司網站、桌面應用程序及移動應用程序登入的醫脈通平台用户及北京美迪康信息諮詢有限公司("北京美迪康")(為公司擁有60%權益之附屬公司)用户,集團約有550萬註冊用户,其中約310萬用户為執業醫師,佔截至同日中國執業醫師總數約75%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.